 |
|
Cerebrospinal Fluid Amine Metabolites in Acute Schizophrenia
Robert M. Post, MD;
Ed Fink, MD;
William T. Carpenter, Jr, MD;
Frederick K. Goodwin, MD
Arch Gen Psychiatry. 1975;32(8):1063-1069.
Abstract
The metabolites of serotonin, dopamine, and norepinephrine, 5-hydroxyindoleacetic acid (5HIAA), homovanillic acid (HVA), and 3-methoxy-4-hydroxy-phenylethylene glycol (MHPG), respectively, were studied in cerebrospinal fluid of patients with acute schizophrenia. Base line levels of these metabolites were not significantly different from those in normal, neurological, and affectively ill controls. Accumulations of 5HIAA and HVA following probenecid administration, which provide a measure of serotonin and dopamine turnover, were also not significantly different in patients with acute schizophrenia and affective illness.
After patients had recovered from their acute schizophrenic illness, HVA accumulations were significantly reduced. We discuss results in relation to amine hypotheses of schizophrenia and the suggestion that altered dopamine metabolism may reflect a biological change predisposing to acute schizophrenia.
Author Affiliations
From the Adult Psychiatry Branch (Drs. Post, Fink, and Carpenter) and the Laboratory of Clinical Science (Dr. Goodwin), National Institute of Mental Health, Bethesda, Md. Dr. Fink is now with Butler Hospital, Providence, RI.
Footnotes
Accepted for publication March 25, 1975.
Reprint requests to the Section on Psychobiology, Adult Psychiatry Branch, National Institute of Mental Health, Bldg 10, Rm 3S 239, 9000 Rockville Pike, Bethesda, MD 20014 (Dr. Post).
 CiteULike  Connotea  Delicious  Digg  Facebook  Reddit  Technorati  Twitter
What's this?
THIS ARTICLE HAS BEEN CITED BY OTHER ARTICLES
|
Cerebrospinal Fluid and Plasma Monoamine Metabolites and Their Relation to Psychosis: Implications for Regional Brain Dysfunction in Schizophrenia
Pickar et al.
Arch Gen Psychiatry 1990;47:641-648.
ABSTRACT
Dopamine Metabolism and Disposition in Schizophrenic Patients: Studies Using Debrisoquin
Maas et al.
Arch Gen Psychiatry 1988;45:553-559.
ABSTRACT
Noradrenergic Function in Schizophrenia
Glazer et al.
Arch Gen Psychiatry 1987;44:898-904.
ABSTRACT
Growth Hormone Response to Apomorphine
Ferrier et al.
Arch Gen Psychiatry 1987;44:93-93.
ABSTRACT
Relation of Clinical Symptoms to Apomorphine-Stimulated Growth Hormone Release in Mood-Incongruent Psychotic Patients
Zemlan et al.
Arch Gen Psychiatry 1986;43:1162-1167.
ABSTRACT
Dopamine Metabolism in the Cerebrospinal Fluid of Drug-Free Schizophrenic Patients With and Without Cortical Atrophy
van Kammen et al.
Arch Gen Psychiatry 1986;43:978-983.
ABSTRACT
Dopamine-beta-hydroxylase activity and homovanillic acid in spinal fluid of schizophrenics with brain atrophy
van Kammen et al.
Science 1983;220:974-977.
ABSTRACT
Increased Brain Dopamine and Dopamine Receptors in Schizophrenia
Mackay et al.
Arch Gen Psychiatry 1982;39:991-997.
ABSTRACT
Aberrant Monoamine Metabolite Levels in CSF and Family History of Schizophrenia: Their Relationships in Schizophrenic Patients
Sedvall and Wode-Helgodt
Arch Gen Psychiatry 1980;37:1113-1116.
ABSTRACT
Schizophrenia: elevated cerebrospinal fluid norepinephrine
Lake et al.
Science 1980;207:331-333.
ABSTRACT
Probenecid-Induced Norepinephrine Elevations in Plasma and CSF
Lake et al.
Arch Gen Psychiatry 1978;35:237-240.
ABSTRACT
Dopamine Excretion and Vulnerability to Drug-Induced Parkinsonism: Schizophrenic Patients
Crowley et al.
Arch Gen Psychiatry 1978;35:97-104.
ABSTRACT
Increased Norepinephrine Levels and Decreased Dopamine-{beta}-Hydroxylase Activity in Primary Autism
Lake et al.
Arch Gen Psychiatry 1977;34:553-556.
ABSTRACT
|
